drugset / Trial / NCT05267769

Clinical Trial on Pharmacokinetics and Tolerability of AP707

NCT05267769 ↗

Phase 1 Completed 12 enrolled CannaXan GmbH
NaSingle-groupOpen-labelOther

Summary

Brief Summary:This study aims to investigate the uptake of AP707, a preparation from cannabis flowers, into the bloodstream after in single administration in healthy volunteers.

Timeline

Start
2022-03-02
Primary completion
2022-04-03
Completion
2022-04-03

Drugs

EvaluationDrugModalityDoseRoute
Subject AP707 Unknown — Other

Indications

No indication recorded.